Response to Haseeb et al

Philip O Katz¹, Kerry B Dunbar^{2

3}, Felice H Schnoll-Sussman¹, Katarina B Greer⁴, Rena Yadlapati⁵, Stuart Jon Spechler^{6

7}

Affiliations

¹ Department of Medicine, Division of Gastroenterology and Hepatology, Jay Monahan Center for Gastrointestinal Health, Weill Cornell Medicine, New York, New York, USA.
² Department of Medicine, University of Texas Southwestern Medical Center, Dallas VA Medical Center, Dallas, Texas, USA.
³ Gastroenterology and Hepatology, Dallas VA Medical Center, Dallas, Texas, USA.
⁴ Department of Medicine, Case Western Reserve University School of Medicine, Cleveland Louis Stokes VA Medical Center, Cleveland, Ohio, USA.
⁵ Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, California, USA.
⁶ Division of Gastroenterology, Baylor University Medical Center at Dallas, Dallas, Texas, USA.
⁷ Center for Esophageal Diseases, Baylor University Medical Center at Dallas, Dallas, Texas, USA.

Comment

Philip O Katz et al. Am J Gastroenterol. 2022.

. 2022 Dec 1;117(12):2084-2085.

doi: 10.14309/ajg.0000000000002004.

Philip O Katz¹, Kerry B Dunbar^{2

3}, Felice H Schnoll-Sussman¹, Katarina B Greer⁴, Rena Yadlapati⁵, Stuart Jon Spechler^{6

7}

¹ Department of Medicine, Division of Gastroenterology and Hepatology, Jay Monahan Center for Gastrointestinal Health, Weill Cornell Medicine, New York, New York, USA.
² Department of Medicine, University of Texas Southwestern Medical Center, Dallas VA Medical Center, Dallas, Texas, USA.
³ Gastroenterology and Hepatology, Dallas VA Medical Center, Dallas, Texas, USA.
⁴ Department of Medicine, Case Western Reserve University School of Medicine, Cleveland Louis Stokes VA Medical Center, Cleveland, Ohio, USA.
⁵ Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, California, USA.
⁶ Division of Gastroenterology, Baylor University Medical Center at Dallas, Dallas, Texas, USA.
⁷ Center for Esophageal Diseases, Baylor University Medical Center at Dallas, Dallas, Texas, USA.

No abstract available

Comment on

Letter to the Editor in Response to ACG Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease.
Haseeb M, McCarty TR, Jirapinyo P, Thompson CC. Haseeb M, et al. Am J Gastroenterol. 2022 Dec 1;117(12):2083. doi: 10.14309/ajg.0000000000001967. Am J Gastroenterol. 2022. PMID: 36002917 No abstract available.

1. Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2022;117(1):27–56.
1. Haseeb M, McCarty TR, Jirapinyo P, et al. Letter to the editor in response to the ACG guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2022;117(12):2083.
1. Huang X, Chen S, Zhao H, et al. Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: A systematic review with meta-analysis. Surg Endosc 2017;31(3):1032–44.
1. Trad KS, Barnes WE, Prevou ER, et al. The TEMPO trial at 5 years: Transoral fundoplication (TIF 2.0) is safe, durable, and cost-effective. Surg Innov 2018;25(2):149–57.
1. Testoni S, Hassan C, Mazzoleni G, et al. Long-term outcomes of transoral incisionless fundoplication for gastro-esophageal reflux disease: Systematic-review and meta-analysis. Endosc Int Open 2021;09(2):E239–46.